California medical device maker Volcano manages releases record preliminary 4th-quarter revenues, touting its leadership position at this year's J.P. Morgan healthcare conference.

Medical device company Volcano (NSDQ:VOLC) unveiled a preliminary look at its Q4 and 2012 financial results, saying it expects record sales of more than $102 million for the quarter.

If it hits that target, Volcano's full-year sales will amount to nearly $392 million, a jump of about 10% over 2011.

Sales were partly driven by a 42% increase in disposable fractional flow reserve products, a segment expected to be worth about $27.2 million in sales during the 3 months ended December 31.